AU593244B2 - Antipsychotic fused-ring pyroidinylpiperazine derivatives - Google Patents

Antipsychotic fused-ring pyroidinylpiperazine derivatives

Info

Publication number
AU593244B2
AU593244B2 AU56795/86A AU5679586A AU593244B2 AU 593244 B2 AU593244 B2 AU 593244B2 AU 56795/86 A AU56795/86 A AU 56795/86A AU 5679586 A AU5679586 A AU 5679586A AU 593244 B2 AU593244 B2 AU 593244B2
Authority
AU
Australia
Prior art keywords
pyroidinylpiperazine
antipsychotic
fused
derivatives
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU56795/86A
Other languages
English (en)
Other versions
AU5679586A (en
Inventor
James Stewart New
Joseph P. Yevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU5679586A publication Critical patent/AU5679586A/en
Application granted granted Critical
Publication of AU593244B2 publication Critical patent/AU593244B2/en
Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-MYERS SQUIBB COMPANY Request to Amend Deed and Register Assignors: BRISTOL-MYERS COMPANY
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU56795/86A 1985-05-06 1986-04-29 Antipsychotic fused-ring pyroidinylpiperazine derivatives Expired AU593244B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06
US731201 1985-05-06

Publications (2)

Publication Number Publication Date
AU5679586A AU5679586A (en) 1986-11-13
AU593244B2 true AU593244B2 (en) 1990-02-08

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56795/86A Expired AU593244B2 (en) 1985-05-06 1986-04-29 Antipsychotic fused-ring pyroidinylpiperazine derivatives

Country Status (25)

Country Link
JP (1) JPH0753728B2 (ja)
KR (1) KR940000829B1 (ja)
CN (1) CN1017901B (ja)
AT (1) AT398572B (ja)
AU (1) AU593244B2 (ja)
BE (1) BE904724A (ja)
CA (1) CA1278792C (ja)
CH (1) CH672787A5 (ja)
DE (1) DE3615180C2 (ja)
DK (1) DK165745C (ja)
EG (1) EG18206A (ja)
ES (6) ES8801250A1 (ja)
FI (1) FI85484C (ja)
FR (1) FR2581385B1 (ja)
GB (1) GB2174703B (ja)
GR (1) GR861149B (ja)
HU (1) HU195509B (ja)
IE (1) IE59201B1 (ja)
IT (1) IT1208607B (ja)
LU (1) LU86421A1 (ja)
MY (1) MY100777A (ja)
NL (1) NL8601146A (ja)
PT (1) PT82523B (ja)
SE (1) SE465270B (ja)
ZA (1) ZA862046B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−2(1h)−オン誘導体セロトニンアンタゴニスト
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
GB2174703B (en) 1988-10-26
HU195509B (en) 1988-05-30
FI85484B (fi) 1992-01-15
DK165745C (da) 1993-06-14
DE3615180C2 (de) 1996-03-07
JPH0753728B2 (ja) 1995-06-07
HUT43848A (en) 1987-12-28
GR861149B (en) 1986-09-09
IT1208607B (it) 1989-07-10
NL8601146A (nl) 1986-12-01
ES8900253A1 (es) 1989-05-16
ATA121486A (de) 1994-05-15
SE8602061D0 (sv) 1986-05-05
GB2174703A (en) 1986-11-12
ES8801250A1 (es) 1987-12-16
AU5679586A (en) 1986-11-13
LU86421A1 (fr) 1986-12-05
FI85484C (fi) 1992-04-27
ES554659A0 (es) 1987-12-16
FR2581385A1 (fr) 1986-11-07
CN86103071A (zh) 1987-03-18
GB8610810D0 (en) 1986-06-11
ES9000005A1 (es) 1989-11-01
ES557809A0 (es) 1988-09-01
ES557855A0 (es) 1989-05-16
PT82523A (en) 1986-06-01
ES8802149A1 (es) 1988-04-01
ZA862046B (en) 1986-11-26
SE465270B (sv) 1991-08-19
ES557757A0 (es) 1988-04-01
IE59201B1 (en) 1994-01-26
ES8900138A1 (es) 1989-01-16
ES557839A0 (es) 1989-01-16
FI861820A0 (fi) 1986-04-30
DK207186D0 (da) 1986-05-05
IE861193L (en) 1986-11-06
AT398572B (de) 1994-12-27
BE904724A (fr) 1986-11-05
MY100777A (en) 1991-02-14
SE8602061L (sv) 1986-11-07
FI861820A (fi) 1986-11-07
CH672787A5 (ja) 1989-12-29
DK165745B (da) 1993-01-11
JPS61268681A (ja) 1986-11-28
DE3615180A1 (de) 1986-11-06
KR940000829B1 (ko) 1994-02-02
CN1017901B (zh) 1992-08-19
EG18206A (en) 1992-09-30
PT82523B (pt) 1988-10-14
ES8802614A1 (es) 1988-09-01
KR860009008A (ko) 1986-12-19
CA1278792C (en) 1991-01-08
FR2581385B1 (fr) 1991-10-04
DK207186A (da) 1986-11-07
IT8620313A0 (it) 1986-05-06

Similar Documents

Publication Publication Date Title
AU572402B2 (en) 25-avermectin derivatives
AU5912086A (en) Substituted 3-phenyl-cyanopyrrole derivatives
AU583607B2 (en) Indole derivatives
AU585351B2 (en) 3-benzazepine derivatives
AU583343B2 (en) Heterocyclic compounds
AU6418286A (en) 3-quinuclidinylmethyl derivatives
AU591210B2 (en) 1-acyl-2-aminomethyl azacylclic derivatives
AU6416986A (en) Heterocyclic compounds
AU6398586A (en) Benzoheterocyclylcarboxamide derivatives
AU589685B2 (en) New derivatives
AU6538686A (en) 5-phenyl-2-oxazole derivatives
AU6101086A (en) 7-formamidoceph-3-em-4-carboxylate derivatives
AU6150386A (en) Guanine derivatives
AU593244B2 (en) Antipsychotic fused-ring pyroidinylpiperazine derivatives
AU5397486A (en) Heterocyclic derivatives
AU5638686A (en) Cyclohexylamidazole derivatives
AU562773B2 (en) Tetrahydroimidazoquinazolinone derivatives
AU6202986A (en) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one derivatives
AU581066B2 (en) Cyanoalkanimidamidophenylpyridazinone derivatives
AU5511986A (en) 2-arylbenzothiazine derivatives
AU561320B2 (en) Clycoside derivatives
AU5363090A (en) Novel terahydroisoquinoline derivatives
AU576962B2 (en) Substituted hexahydro arylquinolizine derivatives
AU6031086A (en) Dihydroquinolinone derivatives
AU586700B2 (en) N-sulfanoyl-3-halo-propionamidine derivatives